The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Curis, Inc. - Biotechnology Company Focused on Development of Therapeutics for Treatment of Cancer Discusses Clinical Development and Growth Drivers

SNNLive spoke with James Dentzer, President & CEO of Curis, Inc. (NASDAQ: CRIS), at the BIO CEO & Investor Conference 2019 in New York, NY.

Share With

Wednesday, March 06, 2019

   

© 2019 Stock News Now